Team uncovers novel epigenetic changes in leukemia

May 9, 2017

UT Health San Antonio researchers discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone marrow. The mutations also play a role in a large majority of low-grade gliomas, which are among the most-treatable brain tumors.


Team offers new technique to treat stroke risk factor

May 2, 2017

Physicians of The University of Texas Health Science Center, now called UT Health San Antonio, recently introduced a new technique to treat atrial fibrillation. This is a common heart rhythm disorder and major risk factor for stroke.

Heart




UT Health diabetes breakthrough increases insulin-producing cells

April 20, 2017

A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the novel approach would also allow Type 2 diabetics to stop insulin shots. The discovery, made at The University of Texas Health Science Center, now called UT Health San Antonio, increases the types of pancreatic cells that secrete insulin.

Diabetes research breakthrough at UT Health San Antonio


Study: Liver cancer in Latinos linked to contaminated food

April 5, 2017

A new UT Health San Antonio study found that Latinos with liver cancer had much higher levels of aflatoxins than those without liver cancer. Alfatoxins are cancer-causing chemicals produced by mold that can contaminate improperly stored foods.